SCHEMBL16795808

SCHEMBL16795808

CC(O)(C(=O)O)C(O)c1ccccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 2/20 0.45
ADRB1 P08588 2/20 0.45
CYP2D6 P10635 1/20 0.45
NFKB1 P19838 1/20 0.45
HIF1A Q16665 1/20 0.45
BLM P54132 1/20 0.44
ACP3 P15309 1/20 0.40
CASP1 P29466 1/20 0.40
CXCL8 P10145 2/20 0.40
AOC3 Q16853 1/20 0.39
FDFT1 P37268 1/20 0.38
HSD11B1 P28845 1/20 0.37
ALDH1A1 P00352 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36
PDK4 Q16654 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28368711 1.00 ADRB2 (0.45) ADRB2ADRB1CYP2D6NFKB1HIF1A
SCHEMBL28364834 1.00 ADRB2 (0.45) ADRB2ADRB1CYP2D6NFKB1HIF1A
SCHEMBL15540082 1.00 ADRB2 (0.45) ADRB2ADRB1CYP2D6NFKB1HIF1A
SCHEMBL15538970 1.00 ADRB2 (0.45) ADRB2ADRB1CYP2D6NFKB1HIF1A
SCHEMBL15538388 0.81 ACP3 (0.41) CYP2D6ACP3ALDH1A1L3MBTL1PDK1
SCHEMBL28884524 0.81 ACP3 (0.41) CYP2D6ACP3ALDH1A1L3MBTL1PDK1
SCHEMBL16795796 0.81 ACP3 (0.41) CYP2D6ACP3ALDH1A1L3MBTL1PDK1
SCHEMBL15539624 0.81 ACP3 (0.41) CYP2D6ACP3ALDH1A1L3MBTL1PDK1
SCHEMBL28364909 0.81 ACP3 (0.41) CYP2D6ACP3ALDH1A1L3MBTL1PDK1
SCHEMBL15539615 0.81 PDK1 (0.38) CXCL8ALDH1A1L3MBTL1PDK1PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116234798-A Sulfamate derivative compounds for the treatment or alleviation of psychotic disorders 生物药品解决方案有限公司 2023-06-06 CN disclosed
EP-3079686-A1 SULFAMATE DERIVATIVE COMPOUND FOR USE IN PREVENTING OR TREATING EPILEPSY Bio-Pharm Solutions Co., Ltd. (KR) 2016-10-19 EP disclosed
EP-3079685-A1 SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING PAIN Bio-Pharm Solutions Co., Ltd. (KR) 2016-10-19 EP disclosed
WO-2015088273-A9 SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING PAIN BIO-PHARM SOLUTIONS, CO., LTD. (KR) 2015-08-06 WO disclosed
WO-2015088273-A1 SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING PAIN BIO-PHARM SOLUTIONS, CO., LTD. (KR) 2015-06-18 WO disclosed
WO-2015088271-A1 SULFAMATE DERIVATIVE COMPOUND FOR USE IN PREVENTING OR TREATING EPILEPSY BIO-PHARM SOLUTIONS, CO., LTD. (KR) 2015-06-18 WO disclosed